1. Home
  2. GAIA vs ATYR Comparison

GAIA vs ATYR Comparison

Compare GAIA & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$3.41

Market Cap

84.9M

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.95

Market Cap

69.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
ATYR
Founded
1988
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.9M
69.2M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
GAIA
ATYR
Price
$3.41
$0.95
Analyst Decision
Strong Buy
Hold
Analyst Count
1
8
Target Price
$9.00
$4.20
AVG Volume (30 Days)
57.8K
2.7M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
18.52
N/A
EPS
N/A
N/A
Revenue
$4,000,000.00
N/A
Revenue This Year
$11.55
N/A
Revenue Next Year
$11.08
$18,728.62
P/E Ratio
N/A
N/A
Revenue Growth
48.15
N/A
52 Week Low
$2.93
$0.64
52 Week High
$6.39
$7.29

Technical Indicators

Market Signals
Indicator
GAIA
ATYR
Relative Strength Index (RSI) 52.94 54.09
Support Level $3.34 $0.67
Resistance Level $4.23 $1.09
Average True Range (ATR) 0.16 0.09
MACD 0.04 -0.00
Stochastic Oscillator 82.47 44.21

Price Performance

Historical Comparison
GAIA
ATYR

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: